Population Pharmacokinetics of Nicotine and Its Metabolites I. Model Development

Author： Levi Micha Dempsey Delia Benowitz Neal Sheiner Lewis

ISSN： 1567-567X

Source： Journal of Pharmacokinetics and Pharmacodynamics, Vol.34, Iss.1, 2007-02, pp. : 5-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population Pharmacokinetics of Heroin and its Major Metabolites

By Rook Elisabeth J. Huitema Alwin D.R. Wim van den Brink van Ree Jan M. Beijnen Jos H.

Clinical Pharmacokinetics, Vol. 45, Iss. 4, 2006-01 ,pp. : 401-417

Adis International

Access to resources Recommend Favorite

A Mechanism-Based Population Pharmacokinetic Model for Characterizing Time-Dependent Pharmacokinetics of Midostaurin and its Metabolites in Human Subjects

By Yin Ophelia Q.P. Wang Yanfeng Schran Horst

Clinical Pharmacokinetics, Vol. 47, Iss. 12, 2008-01 ,pp. : 807-816

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of Cycloplatam. I. Development of the Population Model for Description of the Pharmacokinetic and Pharmacodynamic Processes Involving Cycloplatam

By Singin A. S.

Pharmaceutical Chemistry Journal, Vol. 37, Iss. 10, 2003-10 ,pp. : 513-517

Springer Publishing Company

Access to resources Recommend Favorite

Population Pharmacokinetics of Ifosfamide and its Dechloroethylated and Hydroxylated Metabolites in Children with Malignant Disease: A Sparse Sampling Approach

By Kerbusch T.

Clinical Pharmacokinetics, Vol. 40, Iss. 8, 2001-01 ,pp. : 615-625

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of Midazolam and Its Metabolites during Venoarterial Extracorporeal Membrane Oxygenation in Neonates

By Ahsman Maurice J.

Clinical Pharmacokinetics, Vol. 49, Iss. 6, 2010-06 ,pp. : 407-419

Adis International

Access to resources Recommend Favorite